These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12569028)

  • 61. Novel interpenetrating network chitosan-poly(ethylene oxide-g-acrylamide) hydrogel microspheres for the controlled release of capecitabine.
    Agnihotri SA; Aminabhavi TM
    Int J Pharm; 2006 Nov; 324(2):103-15. PubMed ID: 16824710
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A novel approach to prepare tripolyphosphate/chitosan complex beads for controlled release drug delivery.
    Shu XZ; Zhu KJ
    Int J Pharm; 2000 May; 201(1):51-8. PubMed ID: 10867264
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Preparation, characterization, and mucoadhesive properties of chitosan-coated microspheres encapsulated with cyclosporine A.
    Malaekeh-Nikouei B; Sajadi Tabassi SA; Jaafari MR
    Drug Dev Ind Pharm; 2008 May; 34(5):492-8. PubMed ID: 18473231
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Sustained buccal delivery of the hydrophobic drug denbufylline using physically cross-linked palmitoyl glycol chitosan hydrogels.
    Martin L; Wilson CG; Koosha F; Uchegbu IF
    Eur J Pharm Biopharm; 2003 Jan; 55(1):35-45. PubMed ID: 12551702
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Controlled release of interleukin-2 from chitosan microspheres.
    Ozbaş-Turan S; Akbuğa J; Aral C
    J Pharm Sci; 2002 May; 91(5):1245-51. PubMed ID: 11977100
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Preparation and in vitro evaluation of chitosan matrices for colonic controlled drug delivery.
    Zambito Y; Di Colo G
    J Pharm Pharm Sci; 2003; 6(2):274-81. PubMed ID: 12935439
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Controlled release of endothelial cell growth factor from chitosan-albumin microspheres for localized angiogenesis: in vitro and in vivo studies.
    Elçin YM; Dixit V; Gitnick G
    Artif Cells Blood Substit Immobil Biotechnol; 1996 May; 24(3):257-71. PubMed ID: 8773742
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Development of new chitosan-cellulose multicore microparticles for controlled drug delivery.
    Remuñán-López C; Lorenzo-Lamosa ML; Vila-Jato JL; Alonso MJ
    Eur J Pharm Biopharm; 1998 Jan; 45(1):49-56. PubMed ID: 9689535
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Multiparticulate chitosan-dispersed system for drug delivery.
    Shimono N; Takatori T; Ueda M; Mori M; Nakamura Y
    Chem Pharm Bull (Tokyo); 2003 Jun; 51(6):620-4. PubMed ID: 12808235
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In vitro--in vivo evaluation of tableted caseinchitosan microspheres containing diltiazem hydrochloride.
    al-Suwayeh SA; el-Helw AR; al-Mesned AF; Bayomi MA; el-Gorashi AS
    Boll Chim Farm; 2003; 142(1):14-20. PubMed ID: 12680034
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Controlled drug release properties of ionically cross-linked chitosan beads: the influence of anion structure.
    Shu XZ; Zhu KJ
    Int J Pharm; 2002 Feb; 233(1-2):217-25. PubMed ID: 11897426
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Lipoinsulin encapsulated alginate-chitosan capsules: intestinal delivery in diabetic rats.
    Ramadas M; Paul W; Dileep KJ; Anitha Y; Sharma CP
    J Microencapsul; 2000; 17(4):405-11. PubMed ID: 10898081
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Preparation and in vitro release of spray-dried chitosan microspheres for levofloxacin delivery.
    Cai J; Zhang Y; Du W; Nan K
    J Control Release; 2011 Nov; 152 Suppl 1():e70-1. PubMed ID: 22195935
    [No Abstract]   [Full Text] [Related]  

  • 74. Spray-dried carbamazepine-loaded chitosan and HPMC microspheres: preparation and characterisation.
    Filipović-Grcić J; Perissutti B; Moneghini M; Voinovich D; Martinac A; Jalsenjak I
    J Pharm Pharmacol; 2003 Jul; 55(7):921-31. PubMed ID: 12906749
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Preparation of basic fibroblast growth factor chitosan microsphere and its properties].
    Chen W; Liu Z; Yue Y; Wan L; Hu J; Lü B
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2012 Aug; 26(8):989-92. PubMed ID: 23012937
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Controlled release of Bordetella bronchiseptica dermonecrotoxin (BBD) vaccine from BBD-loaded chitosan microspheres in vitro.
    Jiang HL; Park IK; Shin NR; Yoo HS; Akaike T; Cho CS
    Arch Pharm Res; 2004 Mar; 27(3):346-50. PubMed ID: 15089042
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Bacterial-binding chitosan microspheres for gastric infection treatment and prevention.
    Gonçalves IC; Magalhães A; Fernandes M; Rodrigues IV; Reis CA; Martins MC
    Acta Biomater; 2013 Dec; 9(12):9370-8. PubMed ID: 23920152
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Preparation of superoxide dismutase loaded chitosan microspheres: characterization and release studies.
    Celik O; Akbuğa J
    Eur J Pharm Biopharm; 2007 Apr; 66(1):42-7. PubMed ID: 17055712
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Microencapsulation of DNA within alginate microspheres and crosslinked chitosan membranes for in vivo application.
    Alexakis T; Boadi DK; Quong D; Groboillot A; O'Neill I; Poncelet D; Neufeld RJ
    Appl Biochem Biotechnol; 1995 Jan; 50(1):93-106. PubMed ID: 7702366
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The promise of chitosan microspheres in drug delivery systems.
    Varshosaz J
    Expert Opin Drug Deliv; 2007 May; 4(3):263-73. PubMed ID: 17489653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.